Previous 10 | Next 10 |
Pressure BioSciences, Inc. (PBIO) Q1 2019 Earnings Conference Call May 16, 2019 4:30 PM ET Company Participants Richard Schumacher - President & Chief Executive Officer Conference Call Participants Geoffrey Scott - Scott Asset Management. Presentation Operator Goo...
Pressure BioSciences ( OTC:PBIO ): Q1 GAAP EPS of -$2.01. More news on: Pressure BioSciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Q1 Revenue from Newly Created BioPharma and UST Contract Services Significantly Exceeds Services Revenue for All Quarters of 2018 Combined Investor Conference Call Scheduled for Thursday, May 16, 2019 at 4:30 PM EST SOUTH EASTON, MA / ACCESSWIRE / May 16, 2019 / Pressure BioScience...
Conference Call Scheduled for Thursday, May 16 th at 4:30pm ET SOUTH EASTON, MA / ACCESSWIRE / May 15, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2019 financial resul...
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, today announced its CEO succession plan in light of its founder Ri...
Richard T. Schumacher to Step Down as President & CEO on September 9, 2019; Will Remain as Senior Consultant to Support Leadership Transition SOUTH EASTON, MA / ACCESSWIRE / May 1, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the develop...
Pressure BioSciences ( OTC:PBIO ): Q4 GAAP EPS of -$2.93. More news on: Pressure BioSciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Q4 2018 Total Revenue Increases 37% over Q4 2017, Setting New Record Quarterly High; FY 2018 Total Revenue Increases 10% over FY 2017, Setting New Record Annual High; Initial Revenue Reported from New BioPharma Services and UST Businesses; Balance Sheet Improves with Sign...
Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, today announced its plans to host a teleconference to discuss its Q4 and fiscal year 201...
Conference Call Scheduled for Thursday, April 25 th at 4:30pm ET SOUTH EASTON, MA / ACCESSWIRE / April 24, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...